B
Braidwell’s Krystal Biotech KRYS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $100M | Buy |
727,811
+327,067
| +82% | +$45M | 3.42% | 8 |
|
2025
Q1 | $72.3M | Buy |
400,744
+200,244
| +100% | +$36.1M | 2.54% | 13 |
|
2024
Q4 | $31.4M | Buy |
200,500
+31,809
| +19% | +$4.98M | 0.93% | 40 |
|
2024
Q3 | $30.7M | Buy |
168,691
+61,512
| +57% | +$11.2M | 0.87% | 42 |
|
2024
Q2 | $19.7M | Sell |
107,179
-69,910
| -39% | -$12.8M | 0.62% | 47 |
|
2024
Q1 | $31.5M | Sell |
177,089
-19,111
| -10% | -$3.4M | 1.02% | 38 |
|
2023
Q4 | $24.3M | Buy |
196,200
+118,703
| +153% | +$14.7M | 0.89% | 38 |
|
2023
Q3 | $8.99M | Sell |
77,497
-163,902
| -68% | -$19M | 0.28% | 80 |
|
2023
Q2 | $28.3M | Sell |
241,399
-106,637
| -31% | -$12.5M | 0.93% | 39 |
|
2023
Q1 | $27.9M | Sell |
348,036
-10,020
| -3% | -$802K | 0.92% | 43 |
|
2022
Q4 | $28.4M | Buy |
+358,056
| New | +$28.4M | 0.95% | 41 |
|